These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9862143)

  • 1. Fine structural and morphometric studies on gastric parietal cells of peptic ulcer patients after long-term treatment with omeprazole.
    Kobayashi H; Watanabe T; Nakahara A; Mutoh H; Tanaka N; Uchiyama Y
    Arch Histol Cytol; 1998 Oct; 61(4):287-95. PubMed ID: 9862143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in subcellular structures of parietal cells in the rat gastric gland after omeprazole.
    Furuhashi M; Nakahara A; Fukutomi H; Kominami E; Uchiyama Y
    Arch Histol Cytol; 1992 May; 55(2):191-201. PubMed ID: 1497949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.
    Driman DK; Wright C; Tougas G; Riddell RH
    Dig Dis Sci; 1996 Oct; 41(10):2039-47. PubMed ID: 8888719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.
    Stachura J; Konturek SJ; Cieszkowsky M; Dabroś W; Zakrzewska J; Konturek J
    Hepatogastroenterology; 1983 Oct; 30(5):205-10. PubMed ID: 6315556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immuno- and enzyme cytochemical study of the H(+)-K+ ATPase in human parietal cells after administration of tetragastrin and omeprazole.
    Kobayashi A; Araki K; Ando T; Ogata T
    Arch Histol Cytol; 1997 Jun; 60(2):205-14. PubMed ID: 9232184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole-induced pseudohypertrophy of gastric parietal cells.
    Stolte M; Bethke B; Rühl G; Ritter M
    Z Gastroenterol; 1992 Feb; 30(2):134-8. PubMed ID: 1553828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
    Nishi T; Makuuchi H; Weinstein WM
    Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
    McArthur KE; Jensen RT; Gardner JD
    Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell kinetics of the gastric mucosa of patients treated with omeprazole.
    Biasco G; Mordenti P; Brandi G; Paganelli GM; Santucci R; Miglioli M
    Am J Gastroenterol; 1996 Mar; 91(3):621-2. PubMed ID: 8633536
    [No Abstract]   [Full Text] [Related]  

  • 12. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA
    Expert Opin Pharmacother; 2001 Oct; 2(10):1663-70. PubMed ID: 11825309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of omeprazole on ultrastructural changes in gastric parietal cells.
    Karasawa H; Tani N; Miwa T
    Gastroenterol Jpn; 1988 Feb; 23(1):1-8. PubMed ID: 3350276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB; Faulds D; McTavish D
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole inhibits natural killer cell functions.
    Alkim H; Unal S; Okur H; Imir T
    Dig Dis Sci; 2008 Feb; 53(2):347-51. PubMed ID: 17597410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
    Sosnowski M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
    Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
    Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of cytoskeletal filaments during membrane rearrangement in rat parietal cells stimulated with gastrin.
    Namikawa T; Araki K; Ogata T
    Arch Histol Cytol; 1998 Mar; 61(1):47-56. PubMed ID: 9557967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of omeprazole on the ultrastructure of gastric parietal cells.
    Kato S; Fujii T; Nakano K; Naganuma H; Nakagawa H
    J Pediatr Gastroenterol Nutr; 1994 Jul; 19(1):91-6. PubMed ID: 7965485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.